Home

HCC Lung Cancer Program Symposium

Lung Cancer: Emerging Tools in Diagnosis & Management

Join Us for the Harvard Cancer Consortium Lung Cancer Program’s Annual Symposium!

On Wednesday, November 18, 2026, leading experts in lung cancer research and care will gather at the MGB Assembly Row Campus in Somerville, Massachusetts, for the Harvard Cancer Consortium Lung Cancer Program’s Annual Symposium.

This year’s symposium theme, “Lung Cancer: Emerging Tools in Diagnosis and Management,” will highlight new approaches that are shaping the future of lung cancer detection, diagnosis, and care. The program will bring together researchers, clinicians, and trainees from across the Harvard Cancer Consortium (HCC) community to discuss the latest advances, ongoing challenges, and emerging opportunities in the field.

We hope you will join us for a day of learning, collaboration, and discussion as we work together to advance lung cancer research and improve patient outcomes.
Attendance is free, but advance registration is required. Please note that attendance is limited to HCC community members. 

Event Date: November 18, 2026
Location: MGB Assembly Row Campus, 399 Revolution Dr, Somerville, MA 02145

Agenda

Guest Speakers

Rethinking Cancer Diagnosis and Treatment with AI: From Molecular Mechanisms to Clinical Management

Regina Barzilay, PhD School of Engineering Distinguished Professor for AI and Health, MIT

Lung Cancer Molecular Pathology: Translating Discoveries into Patient Care

Ignacio Wistuba, MD Senior Member and Chair, Department of Translational Pathology, Moffitt Cancer Center

Agenda

8:00 – 8:30 AM

Continental Breakfast and Registration

8:30 – 8:35 AM

Introduction

Session I

Moderator TBD

8:35  – 9:15 AM

Regina Barzilay, PhD

School of Engineering,
Distinguished Professor for AI and Health, 
Massachusetts Institute of Technology

Rethinking Cancer Diagnosis and Treatment with AI: From Molecular Mechanisms to Clinical Management

9:15 – 9:45 AM

Hisashi Tsukada, MD, PhD

Brigham and Women's Hospital
Department of Surgery, Division of Thoracic Surgery
Assistant Professor, Harvard Medical School

Title TBD

9:45  – 10:05 AM

Selected Abstract #1 

10:05 – 10:50 AM

Patient Advocate Panel

10:50 – 11:05 AM

Coffee Break

11:05 – 11:25 AM

Selected Abstract #2 

11:25  – 11:30 AM

Lee Nadler, MD

Virginia and D.K. Ludwig Professor of Cancer Research and Education
Associate Director for Education and Training 
Harvard Cancer Center

Pathfinder Presentation

11:30 AM – 1:00 PM

Poster Session and Poster Contest

1:00 – 1:50 PM

Lunch

Session II

Moderator TBD

1:50 – 2:30 PM

Ignacio Wistuba, MD, PhD 

Senior Member and Chair, 
Department of Translational Pathology, 
Moffitt Cancer Center

Lung Cancer Molecular Pathology: Translating Discoveries into Patient Care

2:30 – 2:50 PM

Selected Abstract #3 

2:50 – 3:05 PM

Case-Based Debate & Panel Discussion

3:05 – 3:35 PM

Shadi Abdar Esfahani, M.D.

Director of molecular imaging and theranostics clinical trials, MGB 
Assistant professor of radiology, Harvard Medical School

The Emerging Era of Theranostics

3:35 – 3:55 PM

Selected Abstract #4

3:55 – 4:00 PM

Closing Remarks